Our Purpose

Life-changing power of dermatological skincare

Skin science that works

For over 100 years, Eucerin has been dedicated to advance dermatological skincare science. We are in constant pursuit of scientific breakthroughs and are committed to developing highly tolerable and dermatologically proven solutions for major skin concerns, including:

  • acne,
  • sun protection, and
  • dark spot reduction (sun spots and post-acne marks).

The effects of our skincare products are not just skin deep. If your skin feels better, you feel better.

That's the life-changing power of dermatological skincare.

Dermatologically tested skincare for visible results

We work with leading dermatologist and pharmacist partners around the world to create innovative and effective skincare products they can trust and recommend to you.

Every Eucerin product is:

  • developed with key actives with a dermatologically relevant efficacy profile,
  • proven for efficacy and safety in clinical and dermatological studies, and
  • pleasant and safe to use.

For skin that you feel comfortable in.

From a small pharmacy to a leading skincare brand worldwide

Eucerin's journey began in a small pharmacy owned by Paul C. Beiersdorf in Hamburg.

In 1882, Beiersdorf applied for a patent for a new type of medical dressing, marking the foundation of the Beiersdorf Company. Eight years later, fellow pharmacist Oscar Troplowitz took over the business and began producing products under the Beiersdorf brand. Collaborating closely with pioneering dermatologist Paul Gerson Unna, these products were based on cutting-edge skin research, leading to revolutionary skincare developments for over a century.

Today, Eucerin is one of the most recommended dermo-cosmetic brands by dermatologists and pharmacists worldwide. Our products, available in more than 65 countries, provide effective and safe skincare solutions for aging, hyperpigmentation, and acne.

Sources and studies

1 Self-assessment study conducted with 100 women over 4 weeks in the year 2020, conducted by MWResearch GmbH, Germany

2 T. Mann, W. Gerwat, J. Batzer, K. Eggers, C. Scherner, H. Wenck, F. Stäb, V. Hearing, K-H. Röhm, L. Kolbe (2018). Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase. J Invest Dermatol.138(7): 1601–1608. (Retrieved from PubMed)